These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Use of naloxone in acute poisoning with opiates in substance dependent persons]. Groszek B; Pach J; Kała M Przegl Lek; 1997; 54(6):426-9. PubMed ID: 9333894 [TBL] [Abstract][Full Text] [Related]
6. Rating the presence and severity of opiate dependence. Wang RI; Wiesen RL; Lamid S; Roh BL Clin Pharmacol Ther; 1974 Oct; 16(4):653-8. PubMed ID: 4422361 [No Abstract] [Full Text] [Related]
7. Naloxone and the narcotic abuser: a controlled study of partial blockade. Kurland AA; Hanlon TE; McCabe OL Int J Addict; 1974; 9(5):663-72. PubMed ID: 4155406 [No Abstract] [Full Text] [Related]
8. Naltrexone in the treatment of opiate dependence. Resnick RB; Washton AM; Thomas MA; Kestenbaum RS NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108 [No Abstract] [Full Text] [Related]
9. [Diagnosis and therapy of opiate coma]. Hotujac L; Serić V; Hotujac M Lijec Vjesn; 1987 Oct; 109(10):388-90. PubMed ID: 3669881 [No Abstract] [Full Text] [Related]
10. Narcotic blockade, length of addiction and persistence of etonitazene consumption in rats. Meyer RE; Marcus R; Carnathan G; Cochin J Psychopharmacology (Berl); 1976 Jun; 47(3):273-9. PubMed ID: 9654 [TBL] [Abstract][Full Text] [Related]
11. Clonidine and naloxone for rapid opiate detoxication: comparison between treatments. Masini E; Blandina P; Mannaioni PF; Luciani G Clin Toxicol; 1981 Sep; 18(9):1021-6. PubMed ID: 7318387 [No Abstract] [Full Text] [Related]
12. The opiate addiction test: a clinical evaluation of a quick test for physical dependence on opiate drugs. Ghodse H; Taylor DR; Greaves JL; Britten AJ; Lynch D Br J Clin Pharmacol; 1995 Mar; 39(3):257-9. PubMed ID: 7619665 [TBL] [Abstract][Full Text] [Related]
13. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. Fudala PJ; Bridge TP; Herbert S; Williford WO; Chiang CN; Jones K; Collins J; Raisch D; Casadonte P; Goldsmith RJ; Ling W; Malkerneker U; McNicholas L; Renner J; Stine S; Tusel D; N Engl J Med; 2003 Sep; 349(10):949-58. PubMed ID: 12954743 [TBL] [Abstract][Full Text] [Related]
14. A history of the development of narcotic antagonists for the treatment of narcotic addiction. Martin WR NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106 [No Abstract] [Full Text] [Related]
15. Experimental analysis of conditioning factors in human narcotic addiction. O'Brien CP Pharmacol Rev; 1975 Dec; 27(4):533-43. PubMed ID: 1223916 [No Abstract] [Full Text] [Related]
16. Treating opiate addiction, Part I. Detoxification and maintenance. Harv Ment Health Lett; 2004 Dec; 21(6):4-6. PubMed ID: 15717347 [No Abstract] [Full Text] [Related]
17. Letter: Problems with naloxone. Allen SC Br Med J; 1975 Aug; 3(5980):434. PubMed ID: 1156805 [No Abstract] [Full Text] [Related]
18. Trial of naloxone imperative in children with unexplained reduced consciousness level. Arch Dis Child; 2008 Feb; 93(2):183. PubMed ID: 18209001 [No Abstract] [Full Text] [Related]
19. Addiction pharmacotherapy 2000: new options, new challenges. Rawson RA; McCann MJ; Hasson AJ; Ling W J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198 [TBL] [Abstract][Full Text] [Related]
20. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. Dettmer K; Saunders B; Strang J BMJ; 2001 Apr; 322(7291):895-6. PubMed ID: 11302902 [No Abstract] [Full Text] [Related] [Next] [New Search]